èšæ¶åºŠ
5å
14å
0å
0å
0å
ã¢ã«ãŠã³ãç»é²ããŠãè§£ççµæãä¿åããã
åé¡äžèЧ
1
Duchenneããã¥ã·ã§ã³ããåçãžã¹ãããã£ãŒã®ç æ ã§æ£ããã®ã¯ã©ããã
Xé£é壿§éºäŒããšãã
2
Duchenneããã¥ã·ã§ã³ããåçãžã¹ãããã£ãŒã®çç¶ã§ã¿ãããã®ã¯ã©ããã
ã¬ã¯ãŒãºåŸŽåïŒç»ææ§èµ·ç«ïŒ
3
éççç¡åçã§çºçŸããèªå·±æäœã¯ã©ããã
æã¢ã»ãã«ã³ãªã³åå®¹äœæäœ
4
éççç¡åçã®æ²»çã«çšããããªãã®ã¯ã©ããã
æã³ãªã³è¬æäž
5
50æ³ä»£ä»¥éã«å¥œçºããéªšè «çã¯ã©ããã
転移æ§éªšè «ç
6
éªšè «çã®çç¶ã§ã¿ãããªãã®ã¯ã©ããã
æ»çæ
7
骚幹éšã«å¥œçºããéªšè «çã¯ã©ããã
é¡éªšéªšè «
8
è¯æ§éªšè «çã§ãèŠããã骚èåå¿ã¯ã©ããã
å±€ç¶è¥å
9
転移æ§éªšè «çã§æ£ããã®ã¯ã©ããã
転移æ§éªšè «çã§æ£ããã®ã¯ã©ããã
10
Duchenneããã¥ã·ã§ã³ããåçãžã¹ãããã£ãŒDuchenne muscular dystrophyã§æ£ããã®ã¯ã©ãããïŒ 2014幎 éå»åé¡(远å 詊éš) ååŸåé¡035 ïŒ
è è ¹éšã«ä»®æ§è¥å€§ãèªãã
11
èžè ºè «thymomaã«å䜵ããçŸæ£ã§å€ãã¿ãããã®ã¯ã©ããã ïŒ 2018幎 éå»åé¡ åååé¡071 ïŒ
éççç¡åçmyasthenia gravis
12
éççç¡åçmyasthenia gravisã«ã€ããŠæ£ããã®ã¯ã©ãããïŒ 2014幎 éå»åé¡ ååŸåé¡035 ïŒ
ç¹åŸŽçãªçç¶ã¯çŒçŒäžåã§ããã
13
éççç¡åçã«ã€ããŠæ£ããã®ã¯ã©ãããïŒ 2020幎 éå»åé¡ åååé¡079 ïŒ
èªå·±å ç«çŸæ£ã§ããã
14
Aãã(48æ³ïŒå¥³æ§)ã¯ïŒéççç¡åçmyasthenia gravisã5幎åã«çºçãïŒåæããå¯è ç®è³ªã¹ããã€ãã®å ææ²»çãåããŠèªå® ã§ç掻ããŠãããçŸåšã¯ïŒçŒçŒäžåïŒè€èŠããã³äžäžè¢ã®çåäœäžããããæ¥äžã¯ïŒæéããããã°èº«ã®åãã®ããšã¯ã§ããŠãããæ1åã®å€æ¥å蚺ã¯åŒ·ãç²åŽã䌎ãã倫ãšã¯é¢å©ãïŒé«æ ¡çã®é·å¥³ãš2äººã§æ®ãããŠããããŸãïŒèšªåãµãŒãã¹ã¯èšªåçè·ã®ã¿ãå©çšããŠããã Aããã¯ãæè¿ïŒå£ã®äžãçããïŒé£äºããããããªãããšèšããå£è§ã«çºèµ€ãããïŒèïŒäžå£èããã³é °ç²èã«çœè²ã®ãã®ãä»çããŠïŒãã®äžéšã«åºè¡ãã¿ãããã ãAããã®çç¶ã®åå ãšããŠæãå¯èœæ§ãé«ãã®ã¯ã©ãããïŒ2013幎 éå»åé¡ åååé¡106ïŒ
éµå£ç¡thrushãå£è ã«ã³ãžãçoral candidiasisã
15
å®éè¥åºã«ããå»çšçå矀disuse syndromeã§çããã®ã¯ã©ãããïŒ 2022幎 éå»åé¡ åååé¡084 ïŒ
骚åžåã®äº¢é²
16
å»çšçå矀disuse syndromeãäºé²ããæ¹æ³ã§æ£ããã®ã¯ã©ãããïŒ 2018幎 éå»åé¡ ååŸåé¡044 ïŒ
ã®ãã¹åºå®åŸããã®çå°ºæ§éå
17
å»çšçå矀disuse syndromeã®èª¬æã§é©åãªã®ã¯ã©ãããïŒ 2015幎 éå»åé¡ åååé¡047 ïŒ
äºæ¬¡çã«èµ·ç«æ§äœè¡å§ãçºçããã
18
å»çšçå矀disuse syndromeã瀺ãã®ã¯ã©ãããïŒ 2014幎 éå»åé¡(远å 詊éš) åååé¡017 ïŒ
æ©ããªããšäžè¢çåãäœäžããã
19
骚èè «ã§æ£ããã®ã¯ã©ããã
èºè»¢ç§»ãå€ãã
20
Aå(å°åŠ6幎ç)ã¯ç é¢ã«äœµèšãããé¢å åŠçŽã«éããªãã骚èè «osteosarcomaã®æ²»çãç¶ããŠãããçŸåšïŒèºè»¢ç§»ãããçµæ«æã«ãããåŒåžé害ã®ãã錻è ã«ãã¥ãŒã¬ã§é žçŽ (2L/å)ãåžå ¥äžã§ãããAåã®é£äºæåéã¯æžã£ãŠãããæèã¯æž æã§ããã1é±åŸã«é¢å ã§åæ¥åŒãäºå®ãããŠãããAåã¯ã忥åŒã«åºåžãããããšè©±ããŠããã ãçè·åž«ã®Aåãžã®å¯Ÿå¿ãšããŠé©åãªã®ã¯ã©ãããïŒ 2022幎 éå»åé¡ åååé¡060 ïŒ
åºåžã§ããããã«æºåããããšè©±ãã
21
åç«è ºããã®å¥œçºéšäœã¯ã©ããã
åç«è ºèŸºçžé å
22
äžéæ§ã®ãã¹ãã¹ããã³äžæãã¿ãããåç«è ºããæ²»çè¬ã¯ã©ãã
LHRHã¢ãŽãã¹ã
23
ç²Ÿå·£è «çã§æ£ããã®ã¯ã©ãã
女æ§åä¹³æ¿ãèŠãããããšãããã
24
ç²Ÿå·£è «çã§æãå€ãã®ã¯ã©ãã
ã»ãããŒãïŒç²Ÿäžç®ããïŒ
25
åå€ã®ååŠçæ³ãæå¹ãªç²Ÿå·£è «çã¯ã©ããã
â æã»ãããŒã
26
粟玢éèç€ã§æ£ããã®ã¯ã©ããã
ç·æ§äžåŠã®åå ãšãªãã
27
åèµ·é害治çè¬ã«ããæ¡åŒµç®çãæåŸ ããè¡ç®¡ã¯ã©ãã
ã©ã»ã³åè
28
åç«è ºçprostate cancerã«ã€ããŠæ£ããã®ã¯ã©ãããïŒ2022幎 éå»åé¡ ååŸåé¡049ïŒ
è¡æž PSAå€ãé«å€ãšãªãã
29
åç«è ºçprostate cancerã®æ²»çè¬ã¯ã©ãããïŒ 2015幎 éå»åé¡ ååŸåé¡034 ïŒ
æã¢ã³ããã²ã³è¬
30
åç«è ºçã§åç«è ºå šæåºè¡åŸã«èµ·ãããããã®ã¯ã©ãããïŒ 2009幎 éå»åé¡ ååŸåé¡058 ïŒ
尿倱çŠ
31
ç·æ§çæ®åšã«ã€ããŠæ£ããã®ã¯ã©ãããïŒ 2016幎 éå»åé¡ åååé¡030 ïŒ
åç«è ºã¯çŽè žã®åé¢ã«äœçœ®ããã
32
åèµ·äžå šæ²»çè¬ã®äœµçšçŠå¿ã¯ã©ãããïŒ 2009幎 éå»åé¡ åååé¡064 ïŒ
ãããã°ãªã»ãªã³
33
Aãã(38æ³ïŒç·æ§)ã¯ïŒæ§äº€æã«æå¹ãªé°èã®åèµ·ãåŸãããªãããå蚺ããããAããã¯ïŒæ6æã«åºå€ãïŒæ·±å€12æåã«åž°å® ããçæŽ»ãã¿ãŒã³ããšã£ãŠããã忥ã¯äŒæ¥ã ãç²ããŠå®¶ã§ãŽããŽãããŠããããšãå€ããå€éåèµ·çŸè±¡ã¯ã¿ãšããããŠããïŒæ©èœæ§ã®åèµ·é害ãšèšºæãããã ãæ¬¡ã®ãã¡ïŒAããã«è¡ãããæ²»çæ³ã¯ã©ããã
ã·ã«ãããã£ã«ã®å æ
34
åèµ·é害ãèµ·ããã®ã¯ã©ãããïŒ ç¬¬95å åå101å ïŒ
ç³å°¿ç